Skip to main content

Chloraseptic Total Sore Throat+Cough Lozenges Side Effects

Generic name: benzocaine / dextromethorphan / menthol topical

Note: This document contains side effect information about benzocaine / dextromethorphan / menthol topical. Some dosage forms listed on this page may not apply to the brand name Chloraseptic Total Sore Throat+Cough Lozenges.

Applies to benzocaine/dextromethorphan/menthol topical: mucous membrane lozenge.

Hypersensitivity

Benzocaine:

Frequency not reported: Angioedema

Dextromethorphan:

Rare (less than 0.1%): Fixed-drug eruptions

Frequency not reported: Angioedema[Ref]

Dermatologic

Benzocaine:

Frequency not reported: Contact dermatitis, urticaria

Dextromethorphan:

Frequency not reported: Pruritus, rash, urticaria[Ref]

Local

Benzocaine:

Frequency not reported: Burning, stinging

Menthol:

Frequency not reported: Application site redness/irritation[Ref]

Gastrointestinal

Dextromethorphan:

Frequency not reported: Abdominal pain, diarrhea, gastrointestinal disturbance, nausea, upset stomach, vomiting[Ref]

Psychiatric

Dextromethorphan:

Frequency not reported: Abuse, excitation, insomnia, mental confusion[Ref]

Nervous system

Dextromethorphan:

Frequency not reported: Convulsions, dizziness, drowsiness[Ref]

Hematologic

Benzocaine:

Postmarketing reports: Methemoglobinemia[Ref]

Respiratory

Dextromethorphan:

Frequency not reported: Respiratory depression[Ref]

Cardiovascular

Benzocaine:

Frequency not reported: Edema[Ref]

More about Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol topical)

Related treatment guides

References

1. Stubb S, Reitamo S. Fixed-drug eruption due to dextromethorphan . Arch Dermatol. 1990;126:970-1.

2. Hall RC, Beresford TP, Stickney SK, Nasdahl CS, Coleman JH. Psychiatric reactions produced by respiratory drugs. Psychosomatics. 1985;26:605-8,616-7.

3. Helfer J, Kim OM. Psychoactive abuse potential of Robitussin-DM. Am J Psychiatry. 1990;147:672-3.

4. Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993;86:1151-3.

5. Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med. 1995;13:174-6.

6. Polles A, Griffith JL. Dextromethorphan-induced mania. Psychosomatics. 1996;37:71-4.

7. Bostwick JM. Dextromethorphan-induced manic symptoms in a bipolar patient on lithium. Psychosomatics. 1996;37:571-2.

8. Knowles SR, Weber E. Dextromethorphan anaphylaxis. J Allerg Clin Immunol. 1998;102:316-7.

9. Product Information. Stopain (menthol topical). DRJ Group Inc. 2003.

10. Product Information. Cold and Hot (menthol topical). Major Pharmaceuticals Inc. PROD.

11. Product Information. BENGAY Pain Relieving (menthol topical). Pfizer U.S. Pharmaceuticals Group. 2004.

12. Product Information. Solarcaine Plus Aloe (benzocaine topical). Schering-Plough Healthcare Products. 2005.

13. Product Information. Americaine Hemorrhoidal (benzocaine topical). Novartis Consumer Health. 2005.

14. Product Information. Dermoplast (benzocaine topical). MedTech Inc. 2005.

15. Product Information. Outgro Pain Relief (benzocaine topical). MedTech Inc. 2005.

16. Product Information. Cepacol Lozenges (cetylpyridinium topical). GlaxoSmithKline Inc. 2005.

17. Product Information. Chloraseptic (benzocaine topical). Procter and Gamble Pharmaceuticals. 2005.

18. Product Information. Vagisil Feminine Cream (benzocaine topical). Combe Inc. 2005.

19. Product Information. Lanacane (benzocaine topical). Combe Inc. 2005.

20. Product Information. Hurricaine (benzocaine topical). Beutlich. 2005.

21. Cerner Multum, Inc. UK Summary of Product Characteristics.

22. Throm MJ, Stevens MD, Hansen C. Benzocaine-induced methemoglobinemia in two patients: interdisciplinary collaboration, management, and near misses. Pharmacotherapy. 2007;27:1206-14.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.